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Abstract 
Despite the high frequency of anxiety and depression symptoms in individuals with Autism 
Spectrum Disorder (ASD) and a significant impact of these comorbidities on both individuals 
with ASD and their families, research on the validity of anxiety and depression measures in 
the ASD population is currently lacking. The aim of this study was to explore the 
psychometric properties of the Hospital Anxiety and Depression Scale (HADS; Zigmond & 
Snaith, 1983) in a sample of older adolescents and young adults with ASD. One hundred and 
fifty one participants (UK Transition longitudinal study: N= 106; 75 males, Mage= 16.04 
years, SD= 1.28; Longitudinal Study of Australian Schools Leavers with ASD: N= 45, 30 
males; Mage= 18.35 years, SD= 2.55) completed the HADS and a range of mental health and 
well-being measures. Combination of the Principal Component Analysis and Parallel 
Analysis indicated two factors as an optimal solution in our sample, accounting for 43.77% of 
variance with factors being identical in terms of content with the structure found in the 
general population. Internal consistency was good for the HADS anxiety scale (HADS-A; 
.82-.84) and acceptable for the HADS depression scale (HADS-D; .60-.72). Convergent 
validity of both HADS-A and HADS-D scales was excellent and divergent validity was 
acceptable. Our study represents a significant contribution to the literature by providing an 
initial validation of the HADS in older adolescents and younger adults with ASD. 
Lay Summary: Research on the validity of measurement of anxiety and depression in ASD is 
currently lacking. The aim of this study was to explore the properties of the Hospital Anxiety 
and Depression Scale (HADS) in a sample of 151 young people with ASD. Participants 
completed HADS and a range of mental health and well-being measures. Encouragingly, our 
findings suggest that HADS provides a reliable and valid assessment of anxiety and 
depression in ASD.  
Key words: Hospital Anxiety and Depression scale, HADS, anxiety, depression, autism, 
ASD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
Linked to Autism Spectrum Disorder (ASD) since the original descriptions by Leo 
Kanner (1943) and Hans Asperger (Wing, 1981), anxiety in autism has only become a focus 
of research in the past 20 years. During this time anxiety has been found to be more prevalent 
in ASD when compared to the general population (Kim, Szatmari, Bryson, Streiner, & 
Wilson, 2000; Bellini, 2004; Lopata et al., 2010), and a range of other clinical groups, 
including Down Syndrome (Evans, Canavera, Klinepeter, Taga, & Maccubbin, 2005), 
Conduct Disorder (Green, Gilchrist, & Cox, 2000), Specific Language Impairment (Gillott, 
Furniss, & Walter, 2001), Williams Syndrome (Rodgers, Riby, Janes, Connolly, & 
McConachie, 2012), and non-specific learning disabilities (Gadow et al., 2005;  Gillot & 
Standen, 2007). Recent large scale studies and systematic reviews have suggested the most 
realistic figure for individuals who meet the criteria for clinically significant anxiety to be 
40% among children and adolescents (van Steensel, Bogels, & Perrin, 2011) and up to 60% 
in adults (Buck et al., 2014; Croen et al., 2015; Hofvander et al., 2009; Joshi et al., 2013; 
Lever & Geurts, 2016; Lugnegard, Hallerback, & Gillberg, 2011). 
Studies using parent report (Mayes, Calhoun, Murray, Ahuja, & Smith, 2011) and 
self-report (Hedley & Young, 2006) measures, as well as the clinician administered Autism 
Comorbidity Interview-Present and Lifetime Version (ACI-PL) and DSM-IV criteria (Leyfer 
et al., 2006), have suggested that between 25% and 54% of children and adolescents with 
ASD have depression symptoms. Although there is considerably less research on depression 
in adults with ASD, results suggest that it is one of the most prevalent co-morbid problems in 
this population (Ghaziuddin, Ghaziuddin, & Greden, 2002; Sterling, Dawson, Estes, & 
Greenson, 2007). For example, in a large sample of 374 individuals who had been diagnosed 
with Asperger’s syndrome during adulthood, Cassidy et al. (2014) found that 31% self-
reported depression, 66% self-reported suicidal ideation, and 35% self-reported suicidal 
attempts or plans. A recent systematic review by Wigham, Barton, Parr and Rodgers (2017) 
showed rates of depression tend to be lower when depression-specific measures, rather than 
general measures with a depression subscale, are used, with rates of 29% in childhood and 
35% in adulthood. 
Anxiety and depression have a significant negative impact on the functioning of 
individuals with ASD and their families, often over and above the contribution of core-ASD 
traits and developmental level (Kerns et al., 2015). For example, high levels of anxiety in 
individuals with ASD have been found to be associated with increased levels of repetitive 
behaviours (Lidstone, Uljarević, et al., 2014; Uljarević & Evans, 2016), externalizing 
problems, including aggression and self-injury (Mattila et al., 2010), loneliness (White & 
Roberson-Nay, 2009), insomnia symptoms (Richdale, Baker, Short, & Gradisar, 2014), 
higher need for support and professional help (Leyfer et al., 2006), lower levels of 
employment (Hedley, Uljarević, et al., 2016), as well as with parental concerns for their 
child’s future (Kim et al., 2000) and parents’ own levels of stress and anxiety (Kerns et al., 
2015). 
Despite the high frequency and significant impact of these comorbidities, research on 
the validity and sensitivity of standardised anxiety and depression measures in the ASD 
population has emerged only relatively recently (Davis III, White, & Ollendick, 2014) and 
focussed exclusively on children and younger adolescents (hereinafter defined as ‘youth’). A 
review by Lecavalier et al. (2014) appraised evidence for the suitability of 10 measures for 
assessing anxiety in youth with ASD, concluding that although none of the instruments 
possessed evidence for good or excellent reliability and validity in ASD across all relevant 
indices, several could be considered as ‘appropriate with conditions’. A systematic review by 
Wigham and McConachie (2014) identified the Spence Children's Anxiety Scale (SCAS; 
Spence, 1998), the Revised Children's Anxiety and Depression Scale (Chorpita, Yim, Moffitt, 
Umemoto, & Francis, 2000), and the Screen for Child Anxiety Related Emotional Disorder 
(SCARED; Birmaher et al., 1999) as robust outcome measures for Cognitive Behavioural 
Therapy trials (although see Rodgers et al., 2016 for a discussion on the importance of 
supplementing standard anxiety measures to accommodate for atypical expression of anxiety 
symptoms). 
However, there is considerable overlap between the behavioural symptoms of ASD 
and those attributed to affective disorders and in particular anxiety, despite the distinction in 
their function in the internationally recognised diagnostic classification of disorders (DSM 5, 
2013; ICD-10, 1994). For example, social avoidance and withdrawal can be considered as a 
symptom of anxiety, and also as a potential manifestation of the social communication 
impairment that characterises ASD. Similarly, obsessive and compulsive behaviours are a 
recognised manifestation of particular types of anxiety, but might also be an expression of 
certain types of the core restricted and repetitive behavioural characteristics required for a 
diagnosis of ASD. Thus, an anxiety disorder that manifests with social avoidance and 
ritualistic behaviours, while easily identifiable in a child without ASD, might not be 
recognised as part of the behavioural presentation of a co-occurring mental health disorder 
and so go unnoticed in a child with ASD (Helverschou & Martinsen, 2011; Kerns et al., 
2015; Uljarević, Nuske, & Vivanti, 2016). Further, individuals with ASD might present with 
idiosyncratic symptoms including unusual specific phobias (e.g., vacuum cleaners, toilets) 
and fears of change or novelty (Kerns & Kendall, 2012; Kerns et al., 2016; Mayes et al., 
2013; Renno & Wood, 2013; Rodgers et al., 2016). Therefore careful consideration about 
how best to consider the differential diagnoses in individuals with neurodevelopmental 
disorders including ASD is needed (Uljarević et al., 2016). This includes making judgements 
about the appropriate use of standardised tools such as anxiety instruments, originally 
developed for the general population, with individuals with ASD (Lecavalier et al., 2014; 
Wigham and McConachie, 2014; Wood & Gadow, 2010). Similar concerns have been raised 
with regards to the assessment and diagnosis of depression as, on the one hand, ASD related 
behaviours can be mistakenly interpreted as signs of a co-occurring depression, and on the 
other hand, depressive symptoms can be expressed in atypical ways in individuals with ASD, 
and either missed or ascribed to the underlying ASD (Gotham, Unruh, & Lord, 2015; 
Magnuson & Constantino, 2011; Stewart, Bernard, Pearson, Hasan, & O’Brien, 2006).  
To address these issues, several recent studies have investigated the relevance of 
existing measures for the assessment of anxiety symptoms in ASD youth. Rodgers et al. 
(2016) created the Anxiety Scale for Children – ASD (ASC-ASD) by modifying the Revised 
Children's Anxiety and Depression Scale (RCADS; Chorpita et al., 2000) to incorporate 
items related to intolerance of uncertainty, sensory over-sensitivity and phobias. They 
reported that the newly developed scale had good internal consistency, validity, and 1-month 
test-retest reliability. Kerns et al. (2014; 2015; 2016) have also shown that the Autism 
Spectrum Addendum (ASA) to the Anxiety Disorders Interview Schedule (ADIS; Silverman 
& Albano, 1996), had satisfactory psychometric properties, and convergent and discriminant 
validity in both low-anxiety (Kerns et al., 2014) and treatment seeking (Kerns, Renno, 
Kendall, Wood, & Storch, 2016) samples of children with ASD. Further, Kerns et al (2014) 
reported that the ASA was designed to enable assessment of ambiguous anxiety-like 
symptoms across the following five categories: fears of change, negative reactions to change, 
social fear, unusual phobias, and special interest fears. 
Despite the suggestions that measures originally developed for the assessment of 
anxiety and depression might not be appropriate for use in the ASD population, the use of the 
measures that assess these aspects of mental health disorders in ASD can facilitate the 
investigation of potential commonalities and differences between anxiety and depression in 
ASD and other populations. Indeed, it has been argued that, rather than developing novel 
measures specific for use in individuals with ASD, it might be more useful as a first step, to 
investigate the psychometric properties of standardised measures with well validated 
population norms in the ASD population (Rodgers et al., 2016; Uljarević, 2013). To our 
knowledge, no studies to date have explored in detail the properties of anxiety and depression 
measures in a population of older adolescents or adults with ASD. Thus, this study explores 
the psychometric properties of one such measure - the Hospital Anxiety and Depression Scale 
(HADS; Zigmond & Snaith, 1983) in a sample of older adolescents and young adults with 
ASD. 
The HADS is a brief, self-report questionnaire originally created to assess symptoms 
of anxiety and depression. The HADS was chosen as a potentially useful measure for 
individuals with ASD for several reasons. It provides a quick assessment of both anxiety and 
depression symptoms, has been shown to demonstrate good to excellent psychometric 
properties across general and clinical populations (Bjelland, Dahl, Haug, & Neckelmann, 
2002; Brennan, Worral-Davies, McMillan, Gilbody, & House, 2010), and provides an 
optimal balance between sensitivity and specificity to both clinical conditions. A review by 
Brennan et al. (2010) showed that across 41 studies conducted with general, inpatient and 
outpatient samples, the HADS demonstrated good sensitivity (Major Depressive Disorder 
[MDD]: mean= .82, range: .73–.89; Generalized Anxiety Disorder [GAD]: mean= .72, range: 
.62–.80) and specificity (MDD: mean= .74, range: .60-.84; GAD: mean= .86, range: .79–.90). 
The HADS was designed as a screen for anxiety and depressive symptoms in community and 
non-psychiatric populations and does not include symptoms such as dizziness, headache, 
weight loss, fatigue and anergia, and insomnia) making it more appropriate for assessing 
subtler symptom expression and less prone to sampling symptoms that can be reflective of 
physical symptoms or conditions other than anxiety and depression. Indeed, HADS has been 
shown to effectively sample subtler anxiety and depression symptom expression (Brennan et 
al., 2010). Finally the HADS is freely available, translated and validated in more than 20 
languages, and accessible for use across a range of low-income settings.  
The main goals of this study were to evaluate the factor structure of HADS in a 
sample of older adolescents and young adults with ASD, establish its psychometric 
properties, report convergent and divergent validity, and to examine associations between 
depression and anxiety symptoms, age and ASD severity.  
Methods 
Participants 
One hundred and fifty-one adolescents and young adults with ASD took part in the 
study. One hundred and six were recruited through child mental health services as a part of 
the UK Transition longitudinal study (31 females, 75 males; Mage= 16.04 years, SD= 1.28 
[Merrick et al., 2015]). All participants had a clinical diagnosis of ASD and additional mental 
health difficulties (37.4% Attention Deficit Hyperactivity Disorder [ADHD; 30.8 ADHD 
alone and 6.6% ADHD + additional condition], 25.3% Anxiety [9.9% Anxiety alone, 6.6% 
dual diagnosis of anxiety and depression/low mood, and further 8.8% anxiety plus another 
condition], 14.3% Depression/Low mood, 8.8% Challenging behaviours and Obsessive 
Compulsive Disorder [OCD] each, and 5.5% “other” [e. g., sleep difficulties, conversion 
disorder, hallucinations]).   
Forty-five participants were recruited from the nation-wide Longitudinal Study of 
Australian Schools Leavers with ASD and their families within the Cooperative Research 
Centre for Living with Autism (Autism CRC); 15 females, 30 males; Mage= 18.35 years, SD= 
2.55). The participants were recruited via various channels including state based ASD 
organizations, parent support groups, secondary and tertiary education organizations, 
participant data bases and clinicians. All participants reported receiving a clinical diagnosis 
of ASD (Asperger Syndrome: 46.7%; ASD: 37.8%; High Functioning Autism: 11.1%; 
Autistic Disorder: 2.2%; PDD-NOS: 2.2%). Eighty percent of the Australian sample reported 
that in addition to ASD, they had received a range of additional diagnoses (17.8% anxiety, 
8.9% SLI, 6.7% ADHD, 2.2% depression, and 44% anxiety combined with other diagnoses 
[17.8% anxiety + depression, 13.3% anxiety + depression + ADHD, 8.9% anxiety + ADHD, 
4.4 anxiety + OCD]). Eighty-six percent of individuals who reported receiving a diagnosis of 
anxiety or depression also reported receiving treatment for this diagnosis. The Social 
Responsiveness Scale Second Edition UK sample), and the abridged version of the Autism 
Spectrum Quotient (Australian sample) were used to measure the participants’ autism 
characteristics, with all participants exceeding suggested cut off scores. Descriptive statistics 
are presented in Table 1. 
Insert Table 1 here 
Procedures 
The UK Transition study received a favourable ethical opinion from Newcastle and 
North Tyneside 1 Research Ethics Committee (12/NE/0059).  The Australian Autism CRC 
study was approved by the La Trobe University Human Ethics Committee (14-095), and 
other institutional or organisational ethics committees as appropriate. All individuals read a 
participant information statement about their respective longitudinal study and provided 
informed consent in writing. Parental consent was obtained for individuals younger than 18 
years. UK participants were visited at home to complete questionnaires. Australian 
participants were sent a link to an online survey.   
Measures 
Baseline characterisation measures: 
Autism CRC sample 
Abridged version of the Autism-Spectrum Quotient (AQ-Short; Hoekstra et al., 2011) 
is an abbreviated, 28-item version of the 50-item self-report measure of autistic traits (Baron-
Cohen et al., 2001). Each item is rated on a 4-point Likert scale, from “1 = definitely agree” 
to “4 = definitely disagree”. Unlike the original AQ, where items are coded categorically, the 
full range is endorsed in the AQ-Short. A score of > 65 has a sensitivity of .97 and a 
specificity of .82 for ASD. 
DSM-5 Dimensional Anxiety Scales (DSM-5 DAS; Knappe et al., 2013; Lebeau et al., 
2012; Beesdo-Baum et al., 2012) is a self-report, norm referenced questionnaire designed to 
screen for the presence of anxiety symptoms, with a total score > 14 indicating significant 
anxiety (Beesdo-Baum et al., 2012).  
Patient Health Questionnaire-9 (PHQ-9; Kroenke et al., 2001) is a 9-item, self-report, 
norm referenced, questionnaire designed to screen for the presence of depression across 
general and clinical populations. The PHQ-9 provides two types of cut-off scores (1) 
normal/minimal (0-9), moderate (10-14), moderately severe (15-19), severe (20+), and also a 
cut-off >10 as indicative of major depression (sensitivity of .88 and a specificity of .88). 
UK sample 
Social Responsiveness Scale (SRS; Constantino & Gruber, 2005) is a 65 items, self-
reported measure designed to index autism trait severity. It provides total score and subscale 
scores for social awareness, cognition, communication, motivation, and repetitive behaviour. 
The SRS-2 has good internal consistency (α .72–.93), and excellent sensitivity and specificity 
(≥ .92; Constantino & Gruber, 2005). 
The Strengths and Difficulties Questionnaire (SDQ; Goodman, Meltzer, & Bailey, 
1998) is a measure of psychological well-being assessing emotional, conduct, hyperactivity, 
and peer problems, as well as prosocial behaviours. It consists of 25 items with each item 
rated on a 3-point Likert scale ranging from “not true” to “certainly true.” In this study we 
focused on the emotional problems subscale (scores ≤ 5 indicate no problems, 6 borderline 
and 7-10 abnormal).  
Measures of Anxiety, Depression and Well-being: 
Both Samples 
The Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) is a 
norm referenced questionnaire used to assess anxiety and depression. It contains 14 self-
report items, with seven items forming the Anxiety subscale (HADS-A) and seven items 
forming the Depression subscale (HADS-D). Cut-off score of ≥ 8 has been found to offer the 
best balance between sensitivity and specificity for both HADS-A and HADS-D scales 
(Brennan et al., 2010). 
The Warwick-Edinburgh Mental Well-being Scale (WEMWBS; Clarke et al., 2011) is 
a 14-item scale of mental well-being covering subjective well-being and psychological 
functioning, in which all items are worded positively and address aspects of positive mental 
health. The scale is scored by summing responses to each item answered on a 1- to 5-point 
Likert scale, with higher scores indicating higher levels of positive mental well-being.  
Analysis Plan 
Prior to running analyses, all questionnaires were screened for missing data. Pairwise 
deletion was used to handle missing data. The HADS was examined for latent components 
using the Principal Component Analysis (PCA)1 with direct oblimin rotation. The initial PCA 
was run in order to establish the number of components with eigenvalues over Kaiser’s 
criterion of 1. The Parallel analysis (PA; Horn, 1965; O’Connor, 2000) via the SAS-based 
                                                          
1 Principal Axis Factoring Exploratory Factor Analysis was also run in order to check the pattern of results 
code developed by O’Connor (2000), was used to determine the number of factors that should 
be retained in the final analysis. It has been reported that decisions based on this method are 
more robust and reproducible when compared to Scree Test and relying on Eigen values 
(O’Connor, 2000). The PCA was then rerun specifying the number of factors yielded through 
PA.  
The reliability of extracted HADS factors was determined by using Cronbach’s alpha. 
Convergent validity was examined by exploring the relationship between HADS factors with 
the SDQ subscales, WEMWBS total score, and discriminant validity by exploring the 
relationship with PHQ-9 and DSM-5 DAS scores.  
Results 
Preliminary analyses and descriptive statistics 
Table 1 shows descriptive statistics for the key variables. Since a number of variables 
were not normally distributed, analyses were performed through bootstrapping using 5,000 
resamples to provide more robust statistics (Efron & Tibshirani, 1993; Tabachnick & Fidell, 
2014). Where multiple correlations were run, the significance level was set at .01.  
Factor Analysis 
No more than 0.6% of HADS data were missing for any questionnaire item, and there 
were no systematic differences in missing items. Before factor analysis was run the UK and 
Australian samples were compared in terms of HADS total, HADS-A (Anxiety) and HADS-
D (Depression) scores. The Kruskal-Wallis H test showed that there was no statistically 
significant differences on HADS totals between the participant groups (HADS total: χ2 = .05, 
p = .83; HADS-A: χ2 = .002, p = .96; HADS-D: χ2 = .73, p = .39, respectively).  In addition, 
samples did not differ on any of the individual HADS items (please refer to Table A. 1., 
Appendix A for the full descriptives and comparison statistics). Assumptions of non-
multicollinearity, sampling adequacy, and factorability were all met. The Kaiser-Meyer-Olkin 
(KMO) measure verified the sampling adequacy for the analysis: KMO = .82. Bartlett’s test 
of sphericity indicated that correlations were sufficiently large for PCA (χ2 = 567.71, p<.001).   
The initial PCA indicated that four components had eigenvalues over Kaiser’s 
criterion of 1, accounting for 59.53% of total variance. Parallel analysis showed that factors 3 
onwards had Eigen values less than that of those from simulations and a two-factor solution 
should be retained in the final analysis. Thus the PCA was rerun specifying a two-factor 
solution. Two factors were interpretable as Anxiety (HADS-A) and Depression (HADS-D) 
accounting for 43.77% of variance (Anxiety: 30.07%; Depression: 13.70%). Individual factor 
loadings are presented in Table 223. All of the items loaded in the same way as originally 
designed by Zigmond and Snaith, and replicated in subsequent studies across the life span 
(Bjelland, Dahl, Haug, & Neckelmann, 2002; Brennan, Worral-Davies, McMillan, Gilbody, 
& House, 2010) although as noted (see Table 2), item “I feel tense or wound up” loaded onto 
both HADS-A (.54) and HADS-D (.40) subscales.  
Insert Table 2 Here 
The mean correlation of the anxiety item total score and the HADS-A factor was .71 
(SD= .07), and of mean anxiety items and HADS-D factor .24 (SD= .13). The mean 
depression items-HADS-D factor correlation was .56 (SD= .10), and the mean depression 
items-HADS-A factor correlation was .20 (SD= .11). Item-subscale correlations are presented 
in Table 2. Comparison between the strength of item-subscale correlations for UK and 
                                                          
2 Principal Axis Factoring Exploratory Factor Analysis that was also run resulted in the identical factor structure 
and item order. 
3 PCA was re-run separately in the UK and Australian samples. For both samples, the Kaiser-Meyer-Olkin (KMO) 
measure verified the sampling adequacy for the analysis: KMO = .78 for UK and .74 for Australian sample. 
Bartlett’s test of sphericity indicated that correlations were sufficiently large for PCA (UK: χ2 = 475.01, p<.001; 
Australian sample: χ2 = 246.52, p<.001). PCA indicated 2 factors as optimal solution in both samples, and items 
loaded in identical way in UK and Australian samples, consistent with HADS factor structure in non-ASD 
populations. Anxiety factor accounted for 30.46% of variance in UK and 32.79% in Australian sample, and 
Depression factor accounted for 13.14% of variance in UK and 14.84% in Australian sample.  
Australian samples is presented in Table A. 1., Appendix A. As can be seen, with the 
exception of the item “I look forward with enjoyment to things” that correlated more strongly 
with HADS-D subscale in Australian when compared to UK sample, the strengths of item-
subscale correlations were not statistically different across two samples. 
Reliability 
For the whole sample internal consistency (Cronbach’s α) was good α= .83 (UK: α= 
.84; Australian: α= .82) for the HADS-A scale and acceptable α= .65 (UK: α= .60; 
Australian: α= .73) for HADS-D scale.  
Validity 
Convergent validity was demonstrated by:  
a. Whole sample: significant relationships between HADS-A and HADS-D scales 
and WEMWBS for the whole sample (r= -.45, p < .001, BCa 95% CI [-.59; -.28]; 
r= -.60, p < .001, BCa 95% CI [-.69; -.49]; respectively) 
b. UK sample: significant relationships between HADS-A and HADS-D with the 
SDQ emotional scale (r= .80, p < .001, BCa 95% CI [.72; .86]; r= .29, p = .002, 
BCa 95% CI [.003; .08]; respectively); 
c. Australian sample: significant relationship between HADS-A and DSM-5 DAS 
anxiety scale (r= .71, p < .001, BCa 95% CI [.48; .86]) and between HADS-D and 
PHQ-9 depression scale (r= .56, p < .001, BCa 95% CI [.25; .77]).  
Divergent validity: The HADS-A and HADS-D scales were significantly related (r= 
.34, p < .001; BCa 95% CI [.18; .49]). The HADS-A scale was associated with the PHQ-9 (r= 
.72, p < .001, BCa 95% CI [.55; .85]), and the HADS-D scale was significantly related to the 
DSM-5 DAS scale level (r= .53, p < .001, BCa 95% CI [.25; .70]). The DSM-5 DAS and 
PHQ-9 scales were also significantly inter-related (r= .71, p < .001, BCa 95% CI [.51; .85]). 
The association of the HADS-A and HADS-D with chronological age was not significant (r= 
.04, p= .71, BCa 95% CI [-.15; .22]; r= -.003, p= .98, BCa 95% CI [-.19; .20]; respectively), 
nor was the relationship between the HADS-A and HADS-D scores and ASD severity scores 
(Australian sample: relationship with AQ-28 total: r= .24, p= .23, BCa 95% CI [-.04; .53]; r= 
.28, p= .07, BCa 95% CI [-.01; .53]; respectively; UK sample: relationship with SRS-2 total: 
r= .16, p= .10, BCa 95% CI [-.04; .35]; r= .09, p= .38, BCa 95% CI [-.14; .30]; respectively).  
 
Frequency of Anxiety and Depression 
A comparison between UK and Australian samples showed that HADS-A and HADS-
D scores were similar (HADS-A: t= .12, p = .91; BCa 95% CI [-1.43; 1.73], Cohen’s d= .02 ; 
HADS-D: t= .88, p = .38, BCa 95% CI [-.82; 2.08], Cohen’s d= .15). Sixty percent of the 
total sample scored above the cut off criteria for elevated anxiety and 26.8% above the cut off 
for depression; 75% of individuals who met the cut off criteria for depression also met the cut 
off criteria for elevated anxiety. For separate rates for the UK and Australian samples, please 
see Table 3. Endorsement rates for individual HADS items are presented in Table 2.  
Insert Table 3 Here 
 
Discussion 
The aim of this study was to explore the properties of the HADS (Zigmond & Snaith, 
1983) measure in a sample of older adolescents and young adults with ASD. We firstly 
focussed on whether the HADS showed the same factor structure as that already established 
in non-ASD populations. The two identified factors were identical in terms of content with 
the original structure proposed by Zigmond and Snaith (1983) and subsequently replicated 
across different studies (Bjelland et al., 2002; Brennan et al., 2010). For both the whole 
sample, and for each sub-sample (UK and Australian) when tested separately, internal 
consistency was good for the HADS anxiety scale (HADS-A; .82-.84) and acceptable for the 
HADS depression scale (HADS-D; .60-.73). 
Although no studies to date have compared the factor structure of the HADS in 
individuals with and without ASD, several studies have explored the factor structure of 
various other anxiety measures designed originally for use in typically developing youth, 
when used in youth with ASD. For example, White et al. (2015) failed to show factor 
equivalence of the Multidimensional Anxiety Scale for Children (March et al., 1997) in a 
sample of 109 youth with ASD. White et al. (2015) reported that in the youth with ASD there 
were similar factor loadings for separation/panic and physical symptoms factors to those 
found in typically developing youth, but none of the items loaded onto the factor resembling 
harm avoidance. Furthermore, the authors identified two factors broadly consistent with 
social anxiety (one corresponding to fears about rejection and humiliation, and the second 
one representing fears consistent with performance anxiety), but different in structure from 
the single social anxiety factor reported in the typically developing samples (March et al., 
1997). In addition, three recent studies failed to provide full support for the original factor 
structure of the SCAS-Parent Report (Spence 1998) when used in a sample of children and 
younger adolescents with ASD (Glod et al., 2017; Jitlina et al, 2017; Magiati et al., 2017). 
However, unlike HADS, which assesses only overall levels of anxiety, SCAS-P, in addition 
to providing measure of overall anxiety, also provides scores for the following 6 anxiety 
subtypes: panic attacks and agoraphobia, separation anxiety, physical injury fears, social 
phobia, obsessive-compulsive, and generalized anxiety disorder. 
 In contrast to previous findings, this study has reported an identical HADS factor 
structure in this large sample of older adolescents and young adults with ASD to the one 
commonly reported in both general and non-ASD clinical samples across a wide age range 
(Bjelland et al., 2002; Brennan et al., 2010). Unlike the above reviewed studies in youth with 
ASD that encompassed participants with a wide age range where developmental factors 
strongly influence expression of anxiety (van Steensel et al., 2011), our study had a relatively 
narrow age range and captured a period when expression of anxiety tends to be more stable 
(Lenze & Wetherell, 2011) – thus the HADS might be best used in studies with homogenous 
age groups. Finally, the HADS measures overall or general anxiety rather than specific DSM-
IV or DSM-5 anxiety subtypes. This latter point may explain why all but one item (‘I feel 
tense or wound up’) load into distinct anxiety and depression factors. In the future it will be 
important to evaluate the factor structure of anxiety measures that specifically assess 
individual anxiety subtypes. 
Correlational analyses indicated medium to large negative associations between 
HADS-A and HADS-D scales with positive aspects of well-being (measured by the 
Warwick-Edinburgh Mental Well-being Scale) in the whole sample, a large positive 
correlation between the HADS-A and the DSM-5 Dimensional Anxiety scale (DSM-5 DAS), 
a medium correlation between the HADS-D and the Patient Health Questionnaire-9 (PHQ-9; 
Australian sample), and a medium to large positive correlations between the HADS-A and 
HADS-D scales and the emotional scale of the Strength and Difficulties Questionnaire (SDQ; 
UK sample). These results indicate excellent convergent validity of both HADS-A and 
HADS-D scales. 
It is important to note that while the Australian sample was a sample of opportunity, 
and all families and participating individuals understood that the primary focus of the study 
was to explore educational, vocation and well-being outcomes. In the period around transition 
from secondary school. In contrast, the UK sample recruited individuals who had a clinical 
diagnosis of ASD and additional mental health difficulties. In light of these different 
recruitment foci, it is noteworthy that the two samples did not differ in terms of HADS-A and 
HADS-D scores. However, although all participants in the UK study had additional mental 
health difficulties, this study did not specifically recruit individuals with anxiety and 
depression. Indeed individuals had a wide range of mental health related diagnoses, including 
ADHD, OCD, anger, Tourette’s, sleep difficulties, Conversion disorder, and hallucinations. 
Furthermore, the majority of the Australian sample reported that they had received co-morbid 
diagnoses of anxiety and/or depression as well as other diagnoses including ADHD. 
Considering this, it is probably not surprising that individuals from both sample reported 
similar levels of anxiety and depression.  
Divergent validity of both the HADS-A and HADS-D scales was acceptable as shown 
by non-significant correlations with chronological age and ASD severity, and between the 
HADS-D and DSM-5 DAS. The finding that neither HADS-A or HADS-D scores were 
associated with chronological age was most likely due to the fact that there is a greater 
stability in anxiety and depression in the age range for our study. Sixty percent of our sample 
met the cut off criteria for clinically significant anxiety replicating findings on anxiety 
frequency across adolescence and adulthood in ASD (Buck et al., 2014; Croen et al., 2015; 
Hofvander et al., 2009; Joshi et al., 2013; Lever & Geurts, 2016; Lugnegard, Hallerback, & 
Gillberg, 2011), which is significantly higher than reported frequency in non-ASD 
populations (Lenze & Wetherell, 2011). Frequency of clinical levels of depression (24.7%) 
was somewhat lower than rates of depression reported in previous studies with adults with 
ASD (Cassidy et al., 2014; Hofvander et al., 2009; Lever et al, 2016); however, this finding 
was most likely due to the younger age of participants in our study and due to the fact that 
our study used dedicated measure of depression (Wigham et al., 2017).  
The HADS-A and HADS-D scales were significantly inter-related, showing a 
medium strength relationship, while the HADS-A and PHQ-9 scales (as a measure of 
depression) showed a large positive relationship. These findings are in line with research in 
both the general, and a range of clinical populations showing medium to strong inter-
relationships (r ranging from .45 to .75) between measures of anxiety and depression 
(Bjelland et al., 2002; Cosco et al., 2012; Watson, 2009). Although it has been suggested that 
anxiety and depression are distinguishable at the phenomenological level (Watson, 2009) and 
that high correlations are a hallmark of poor discriminant validity (Clarke & Watson, 1991), 
Burns and Eidelson (1998) have argued that this is to be expected, not because of symptom 
overlap and poor content validity, but because anxiety and depression share underlying 
mechanisms. Indeed, findings from the general population suggest that anxiety and 
depression frequently co-occur, with anxiety commonly predating the occurrence of 
depression (Wetzler & Katz, 1989; Watson, Gamez, & Simms, 2005), and this has been 
mirrored by our results where 75% of individuals who met the cut off criteria for depression 
also met the cut off criteria for elevated anxiety. 
Anxiety and depression frequently occur in people with ASD across the life span 
(Lever & Geurts, 2016; Uljarević et al., 2016; van Steensel, Bogels, & Perrin, 2011; Wigham 
et al., 2017) and have a significant negative impact on both individuals with ASD and their 
families. Although significant progress has been made regarding the assessment of anxiety 
and depression in youth with ASD (Rodgers et al., 2017; Uljarević et al., 2016), as well as in 
terms of understanding underlying mechanisms and developing treatment options for anxiety 
and depression in this population (Davis III, White, & Ollendick, 2014), the ability to 
effectively screen for the presence of anxiety and depression beyond early adolescence is 
currently limited due to the lack of validated measures for this population. 
Several limitations need to be taken into account when interpreting our findings. First, 
as the sample consisted only of participants who were most likely in the normal range of 
intellectual functioning, it is not possible to generalize our finding to individuals with 
intellectual disability. Second, despite all participants meeting suggested cut-off scores for 
ASD on self-report measures of ASD severity (AQ-Short and SRS-2) and reported receiving 
clinical diagnosis of ASD, it was not possible to independently confirm diagnosis of ASD for 
the Australian sample. Finally, our study did not include clinical interview measures of 
anxiety. This will be important to include in the future studies in order to examine the 
sensitivity and specificity of the current HADS cut-off scores for the ASD population and 
provide revisions if necessary. Future studies should replicate our findings and further extend 
them by examining the applicability of HADS across adulthood and in individuals with lower 
cognitive ability, as well as investigating the levels of agreement with subject and informant 
versions of semi-structured and structured clinical interviews (e.g., ADIS).  
Despite the above noted limitations, our study provides a significant contribution to 
the existing literature by presenting the first validation of any measure of anxiety and 
depression in a population of older adolescents and adults with ASD.  The stable factor 
structure, good internal consistency, and solid validity suggest that HADS is a viable measure 
for assessing general levels of anxiety and depression in individuals with ASD. 
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Table 1. Descriptive Statistics 
 Mean (SD)  Shapiro-Wilk 
Test  
Australian 
sample 
  
CA 18.35 (2.55) .93* 
HADS-A  9.23 (3.99) .97 
HADS-D 5.91 (3.68) .94* 
WEMWBS 41.27 (9.64) .93* 
AQ-28  80.18 (9.47) .95 
DSM-5 DAS 13.74 (8.08) .94* 
PHQ-9 9.11 (6.84) .93* 
UK sample   
CA 16.04 (1.28) .96** 
HADS-A  9.23 (4.85) .97* 
HADS-D 5.33 (3.23) .96** 
WEMWBS 45.76 (8.17) .99 
SRS Total   121.84 (23.32) .98 
SDQ emotional 
symptoms  
4.8 (2.51) .97* 
Whole sample   
HADS-A  9.23 (4.6) .98* 
HADS-D 5.50 (3.43) .95** 
WEMWBS 44.42 (8.84) .98* 
Note:  * p < .05; ** p < .01 
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Table 2. Factors Analysis, item-subscale correlations and item endorsement for Hospital Anxiety and Depression Scale 
 
Item 
Factor 
Loading 
Item-subscale Correlations Frequency2 
HADS-A 
r 
HADS-D 
r 
Fisher r-to-z 
Z 
0 (%) 1 (%) 2 (%) 3 (%) 
Factor 1: Anxiety (30.07% of variance)        
I get sudden feelings of panic .82 .78** .20 7.25** 27.3 36.7 24 12 
I get a sort of frightened feeling as if 
something awful is about to happen 
.81 .73** .08 7.3** 23.2 20.5 35.8 20.5 
I get a sort of frightened feeling like 
'butterflies' in the stomach 
.79 .74** .18 6.61** 31.8 47.7 14.6 6 
Worrying thoughts go through my head .70 .77** .37** 5.44** 17.9 37.1 21.2 23.8 
I can sit at ease and feel relaxed .56 .68** .34** 4.09** 17.9 42.4 31.8 7.9 
I feel tense or 'wound up'1 .54 .68** .43** 3.18** 9.3 58.3 21.2 11.3 
I feel restless as I have to be on the 
move 
.52 .56** .12 4.41** 15.9 39.1 31.8 13.2 
Factor 2: Depression (13.70% of variance)         
I look forward with enjoyment to things .73 .24* .70** 5.36** 53.0 29.8 13.2 4.0 
I feel cheerful .66 .37** .65** 3.33** 31.1 49.7 12.6 6.6 
I still enjoy the things I used to enjoy .61 .20 .61** 4.35** 50.3 29.8 15.2 4.6 
35 
 
I can laugh and see the funny side of 
things 
.50 .16 .47** 3.0** 68.7 24.7 4.7 2.0 
I have lost interest in my appearance .47 .14 .54** 3.98** 41.1 25.2 25.2 8.6 
I can enjoy a good book or radio or TV 
program 
.44 -.03 .40** 3.39*** 61.6 28.5 4.6 5.3 
I feel as if I am slowed down .43 .27* .58** 3.32*** 26 49.3 11.3 13.3 
Note: 1this item also loads onto the Depression factor at .40; 2higher score implies higher frequency/severity; * p < .01; ** p < .001. 
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Table 3. Categorization of anxiety and depression across UK and Australian samples 
  UK Sample 
(%) 
Australian Sample 
(%) 
HADS-A1 
Below cut-off 41.5 36.4 
Above Cut-off 58.5 63.6 
HADS-D1 
 
Below cut-off 
 
73.6 
 
72.1 
Above Cut-off 26.4 27.9 
 
SDQ-emotional 
symptoms2 
 
Normal 
 
60 
NA 
Borderline 12.4 
Abnormal 27.6 
 
DSM-5Anxiety Scale3 
 
Below cut-off NA 
 
54.5 
Above cut-off 45.5 
 
 
 
 
 
PHQ-94 
Normal 
NA 
55.6 
Moderate 24.4 
Moderately severe 11.1 
Severe 8.9 
 
Below cut-off 
 
60 
Above Cut-off 40 
Note: 1 For both HADS-A and HADS-D a cut-off score of  ≥ 8 been suggested (Brennan et al., 2010); 2 For 
SDQ-emotional symptoms scores ≤ 5 indicate no problems, 6 borderline and 7-10 abnormal; 3 For DSM-5 
Anxiety Scale cut-off score of > 14 indicates significant anxiety (Beesdo-Baum et al., 2012); 4 PHQ-9 provides 
two types of cut-off scores (1) normal/minimal (0-9), moderate (10-14), moderately severe (15-19), severe 
(20+), and also a cut-off >10 as indicative of major depression (Kroenke et al., 2001). 
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Table A. 1. Item-subscale correlations and item comparison between UK and Australian Samples  
 
Item-subscale Correlations  
UK 
Sample  
Australian 
Sample 
Fisher 
r-to-z 
Z 
UK 
Sample  
Australian 
Sample 
Fisher 
r-to-z 
Z 
UK Sample 
 
Australian 
Sample 
Comparison  
 
 
HADS-A 
r 
HADS-A 
r 
 HADS-D 
r 
HADS-D 
r 
 Mean (SD) Mean (SD) χ2, p 
Factor 1: Anxiety          
I get sudden feelings of panic .77** .87** 1.79 .26** .15 .66 1.18 (1.05) 1.22 (.89) χ2= .07, p= .786 
I get a sort of frightened feeling as if 
something awful is about to happen 
.76** .68** .96 .07 .20 .76 1.47 (1.09) 1.62 (.90) χ2= .73, p= .393 
I get a sort of frightened feeling like 
'butterflies' in the stomach 
.76** .59** 1.82 .24** .09 .88 .96 (.89) .88 (.66) χ2= .30, p= .583 
Worrying thoughts go through my head .79** .73** .82 .35** .43** .54 1.46 (1.05) 1.56 (1.01) χ2= .32, p= .575 
I can sit at ease and feel relaxed .67** .65** .20 .35** .42** .47 1.25 (.92) 1.28 (.64) χ2= 05, p= .822 
I feel tense or 'wound up .66** .76** 1.16 .48** .38** .70 1.36 (.81) 1.30 (.73) χ2= .19, p= .66 
I feel restless as I have to be on the 
move 
.56** .56** 0.00 .16 15 .06 1.49 (.93) 1.24 (.79) χ2= 2.67, p= .104 
Factor 2: Depression   
I look forward with enjoyment to things .23* .38** .95 .66** .84** 2.45* .71 (.85) .62 (.85) χ2= .38, p= .536 
I feel cheerful .40** .36* .27 .64** .73** .98 .91 (.86) .92 (.80) χ2= .001, p= .969 
I still enjoy the things I used to enjoy .18 .29* .67 .60** .61** .09 .74 (.89) .74 (.78) χ2= .001, p= .980 
38 
 
I can laugh and see the funny side of 
things 
.16 .22 .36 .43** .61** 1.43 .36 (.65) .45 (.68) χ2= .65, p= .423 
I have lost interest in my appearance .17 .19 .12 .59** .49** .81 1.00 (1.05) .98 (.87) χ2= .014, p= .906 
I can enjoy a good book or radio or TV 
program 
.001 -.15 .87 .40** .38** .14 .48 (.82) .70 (.76) χ2= 2.68, p= .104 
I feel as if I am slowed down .29** .27 .12 .55** .59** .34 1.05 (.90) 1.24 (1.01) χ2= 1.49, p= .224 
Note: * p < .01; ** p < .001. 
 
 
 
 
